Pacemaker use rose more than 50% between 1993 and 2009, but most of that occurred prior to 2002, a new study shows.
MASSDEVICE ON CALL — A study of pacemaker usage confirmed what most medical device makers already know all too well - the U.S. cardiac rhythm management market just isn't what is used to be.
Stagnancy in the CRM arena has been an anchor weighing down many of the largest medical device makers, including rival medical device makers St. Jude Medical (NYSE:STJ) and Boston Scientific (NYSE:BSX), both of which have lamented the sluggish market and its impact on their quarterly earnings.
Pacemaker use increased 56% between 1993 and 2009, but most of that occurred in the 1990s and has leveled off since hitting a growth peak in 2001, according to a Reuters Health report.
Meanwhile, pacemaker patients have gotten older and sicker, the median age of a dual-chamber pacemaker recipient rising from 73 to 75 years old and exhibiting more co-morbidities than in 1993, according to the newswire.
"The overall market is down in the U.S., but we do see that implant volume is growing," Ishrak said during a conference call with investors last month. "We were pleased to see relative sequential stability in the market."
Teleflex expands a Class I recall for Maquet Servo 163 humidifiers and beats expectations with its...
Nikon, best known for its cameras, moves into medtech with Optos buy
A single human error in India prompts GE Healthcare to issue a warning on 30 years worth of its MRI...
Staar Surgical posts net losses for the 4th quarter and 2014 but comes close to meeting earnings...